Faculty Profiles - MARUYAMA, Shoichi

Papers - MARUYAMA, Shoichi

Division display 121 - 140 of about 410 ／ All the affair displays >>

Impact of etelcalcetide on fibroblast growth factor-23 and calciprotein particles in patients with secondary hyperparathyroidism undergoing haemodialysis Reviewed Open Access

Hashimoto, Y; Kato, S; Kuro-o, M; Miura, Y; Itano, Y; Ando, M; Kuwatsuka, Y; Maruyama, S

Nephrology (Carlton) Vol. 27 ( 9 ) page： 763 - 770 2022.9

New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan Reviewed Open Access

Nakagawa, N; Maruyama, S; Kashihara, N; Narita, I; Isaka, Y

Vol. 26 ( 9 ) page： 909 - 916 2022.9

Mesenchymal stem cells exert renoprotection via extracellular vesicle-mediated modulation of M2 macrophages and spleen-kidney network Reviewed Open Access

Shimamura, Y; Furuhashi, K; Tanaka, A; Karasawa, M; Nozaki, T; Komatsu, S; Watanabe, K; Shimizu, A; Minatoguchi, S; Matsuyama, M; Sawa, Y; Tsuboi, N; Ishimoto, T; Suzuki, HI; Maruyama, S

Vol. 5 ( 1 ) page： 753 2022.7

Predictors of early remission of proteinuria in adult patients with minimal change disease: a retrospective cohort study Reviewed Open Access

Yamamoto, R; Imai, E; Maruyama, S; Yokoyama, H; Sugiyama, H; Takeda, A; Uchida, S; Tsukamoto, T; Tsuruya, K; Akai, Y; Nitta, K; Fukunaga, M; Hayashi, H; Masutani, K; Wada, T; Konta, T; Katafuchi, R; Nishio, S; Goto, S; Tamai, H; Shirasaki, A; Shoji, T; Nagai, K; Nishino, T; Yamagata, K; Kazama, JJ; Hiromura, K; Yasuda, H; Mizutani, M; Naruse, T; Hiramatsu, T; Morozumi, K; Sobajima, H; Saka, Y; Ishimura, E; Ichikawa, D; Shigematsu, T; Sofue, T; Fujimoto, S; Ito, T; Sato, H; Narita, I; Isaka, Y

Sci Rep Vol. 12 ( 1 ) page： 9782 2022.6

Mortality and Cardiovascular Events in Patients With Chronic Kidney Disease and Sleep Apnea Syndrome Open Access

Watanabe, Y; Tanaka, A; Furuhashi, K; Saito, S; Maruyama, S

FRONTIERS IN MEDICINE Vol. 9 page： 899359 2022.5

Protocol for a Phase 1, Open-Label, Multiple-Center, Dose-Escalation Study to Evaluate the Safety and Tolerability of ADR-001 in the Treatment of Immunoglobulin A Nephropathy Open Access

Tanaka, A; Furuhashi, K; Fujieda, K; Maeda, K; Saito, S; Mimura, T; Saka, Y; Naruse, T; Ishimoto, T; Kosugi, T; Kinoshita, F; Kuwatsuka, Y; Shimizu, S; Nakai, Y; Maruyama, S

FRONTIERS IN MEDICINE Vol. 9 page： 883168 2022.5

Effects of bone turnover status on the efficacy and safety of denosumab among haemodialysis patients Reviewed Open Access

Hori, M; Yasuda, K; Takahashi, H; Kondo, C; Shirasawa, Y; Ishimaru, Y; Sekiya, Y; Morozumi, K; Maruyama, S

Sci Rep Vol. 12 ( 1 ) page： 7781 2022.5

Antibody response to double SARS-CoV-2 mRNA vaccination in Japanese kidney transplant recipients Reviewed Open Access

Fujieda, K; Tanaka, A; Kikuchi, R; Takai, N; Saito, S; Yasuda, Y; Fujita, T; Kato, M; Furuhashi, K; Maruyama, S

Sci Rep Vol. 12 ( 1 ) page： 6850 2022.4

Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study. Reviewed

Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Takeda A, Tsukamoto T, Uchida S, Tsuruya K, Shoji T, Hayashi H, Akai Y, Fukunaga M, Konta T, Nishio S, Goto S, Tamai H, Nagai K, Katafuchi R, Masutani K, Wada T, Nishino T, Shirasaki A, Sobajima H, Nitta K, Yamagata K, Kazama JJ, Hiromura K, Yasuda H, Mizutani M, Akahori T, Naruse T, Hiramatsu T, Morozumi K, Mimura T, Saka Y, Ishimura E, Hasegawa H, Ichikawa D, Shigematsu T, Sato H, Narita I, Isaka Y, Japan Nephrotic Syndrome Cohort Study investigators.

J Nephrol Vol. 35 ( 4 ) page： 1135 - 1144 2022.4

A novel renal perivascular mesenchymal cell subset gives rise to fibroblasts distinct from classic myofibroblasts. Reviewed

Minatoguchi S, Saito S, Furuhashi K, Sawa Y, Okazaki M, Shimamura Y, Kaihan AB, Hashimoto Y, Yasuda Y, Hara A, Mizutani Y, Ando R, Kato N, Ishimoto T, Tsuboi N, Esaki N, Matsuyama M, Shiraki Y, Kobayashi H, Asai N, Enomoto A, Maruyama S

Sci Rep Vol. 12 ( 1 ) page： 5389 2022.3

Biopsy-proven CKD etiology and outcomes: Chronic Kidney Disease Japan Cohort (CKD-JAC) study. Reviewed

Hamano T, Imaizumi T, Hasegawa T, Fujii N, Komaba H, Ando M, Nangaku M, Nitta K, Hirakata H, Isaka Y, Wada T, Maruyama S, Fukagawa M

Nephrol Dial Transplant Vol. 38 ( 2 ) page： 384 - 395 2022.3

Lateral spine dual-energy X-ray absorptiometry and the risk of fragility fractures in long-term kidney graft recipients Reviewed

Hori Mayuko, Yasuda Kaoru, Takahashi Hiroshi, Matsuoka Yutaka, Tsujita Makoto, Nishihira Morikuni, Uchida Kazuharu, Morozumi Kunio, Maruyama Shoichi

Related information Vol. 26 ( 7 ) page： 724 - 732 2022.3

Impact of left ventricular hypertrophy on clinical outcomes in patients with dialysis: a single-center study in Japan Reviewed

Nakayama Takafumi, Yamamoto Junki, Ozeki Toshikazu, Yasuda Kaoru, Yamazaki Chikao, Ito Tsuyoshi, Goto Toshihiko, Maruyama Shoichi, Morozumi Kunio, Seo Yoshihiro

J Med Ultrason (2001) Vol. 49 ( 2 ) page： 241 - 252 2022.3

Long-term Effectiveness of a Primary Care Practice Facilitation Program for Chronic Kidney Disease Management: An Extended Follow-up of a Cluster-Randomized FROM-J Study. Reviewed

Imasawa T, Saito C, Kai H, Iseki K, Kazama JJ, Shibagaki Y, Sugiyama H, Nagata D, Narita I, Nishino T, Hasegawa H, Honda H, Maruyama S, Miyazaki M, Mukoyama M, Yasuda H, Wada T, Ishikawa Y, Tsunoda R, Nagai K, Okubo R, Kondo M, Hoshino J, Yamagata K

Nephrol Dial Transplant Vol. 38 ( 1 ) page： 158 - 166 2022.2

Clustering phosphate and iron-related markers and prognosis in dialysis patients Reviewed Open Access

Morooka, H; Tanaka, A; Inaguma, D; Maruyama, S

Global Health Vol. 15 ( 2 ) page： 328 - 337 2022.2

Favorable therapeutic efficacy of low-density lipoprotein apheresis for nephrotic syndrome with impaired renal function. Reviewed

Muso E, Sakai S, Ogura Y, Yukawa S, Nishizawa Y, Yorioka N, Saito T, Mune M, Sugiyama S, Iino Y, Hirano T, Hattori M, Watanabe T, Yokoyama H, Sato H, Uchida S, Wada T, Shoji T, Oda H, Mori K, Kimura H, Ito O, Nishiyama A, Maruyama S, Inagi R, Fujimoto S, Tsukamoto T, Suzuki Y, Honda H, Babazono T, Tsuruya K, Yuzawa Y

Ther Apher Dial Vol. 26 ( 1 ) page： 220 - 228 2022.2

Sex differences in clinical outcomes in Japanese incident dialysis patients: a prospective observational multicenter study Reviewed

Kozaki Yohei, Morinaga Takatoshi, Fukatsu Atsushi, Ito Takeshi, Ishimoto Takuji, Kosugi Tomoki, Inaguma Daijo, Tamai Hirofumi, Maruyama Shoichi

Clin Exp Nephrol Vol. 26 ( 5 ) page： 466 - 475 2022.1

Expression of a Crry/p65 is reduced in acute lung injury induced by extracellular histones Reviewed

Nagano Fumihiko, Mizuno Tomohiro, Imai Masaki, Takahashi Kazuo, Tsuboi Naotake, Maruyama Shoichi, Mizuno Masashi

FEBS Open Bio Vol. 12 ( 1 ) page： 192 - 202 2022.1

Increased Monocyte/Lymphocyte Ratio as Risk Marker for Cardiovascular Events and Infectious Disease Hospitalization in Dialysis Patients. Reviewed

Muto R, Kato S, Lindholm B, Qureshi AR, Ishimoto T, Kosugi T, Maruyama S

Blood Purif Vol. 51 ( 9 ) page： 747 - 755 2021.11

The 30-year Natural History of Non-classic Fabry Disease with an R112H Mutation. Reviewed

Muto R, Inagaki K, Kato N, Maruyama S, Akahori T

Intern Med Vol. 61 ( 11 ) page： 1727 - 1730 2021.11

　 PREV - NEXT 　

<MARUYAMA, Shoichi>

Papers - MARUYAMA, Shoichi